These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 21870140

  • 1. The implementation of tissue banking experiences for setting up a cGMP cell manufacturing facility.
    Arjmand B, Emami-Razavi SH, Larijani B, Norouzi-Javidan A, Aghayan HR.
    Cell Tissue Bank; 2012 Dec; 13(4):587-96. PubMed ID: 21870140
    [Abstract] [Full Text] [Related]

  • 2. Establishing a cGMP pancreatic islet processing facility: the first experience in Iran.
    Larijani B, Arjmand B, Amoli MM, Ao Z, Jafarian A, Mahdavi-Mazdah M, Ghanaati H, Baradar-Jalili R, Sharghi S, Norouzi-Javidan A, Aghayan HR.
    Cell Tissue Bank; 2012 Dec; 13(4):569-75. PubMed ID: 21818570
    [Abstract] [Full Text] [Related]

  • 3. Current regulatory issues in cell and tissue therapy.
    Burger SR.
    Cytotherapy; 2003 Dec; 5(4):289-98. PubMed ID: 12944234
    [Abstract] [Full Text] [Related]

  • 4. Raising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products.
    Wright C, Velickovic Z, Brown R, Larsen S, Macpherson JL, Gibson J, Rasko JE.
    Pathology; 2014 Apr; 46(3):177-83. PubMed ID: 24614714
    [Abstract] [Full Text] [Related]

  • 5. Guidelines to implement quality management systems in microbiology laboratories for tissue banking.
    Vicentino W, Rodríguez G, Saldías M, Alvarez I.
    Transplant Proc; 2009 Oct; 41(8):3481-4. PubMed ID: 19857776
    [Abstract] [Full Text] [Related]

  • 6. [Education of laboratory technicians at graduate school contributes to development of advanced medical sciences and therapeutics].
    Maekawa T.
    Rinsho Byori; 2004 May; 52(5):430-4. PubMed ID: 15206130
    [Abstract] [Full Text] [Related]

  • 7. Implementation of Current Good Manufacturing Practices in a small research laboratory setting.
    Keller CD, Taulbee SM.
    Qual Assur; 1995 Mar; 4(1):83-6. PubMed ID: 8520870
    [Abstract] [Full Text] [Related]

  • 8. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing.
    Korbutt GS.
    Xenotransplantation; 2009 Mar; 16(4):223-8. PubMed ID: 19799762
    [Abstract] [Full Text] [Related]

  • 9. Regulatory aspects of cellular therapy product in Europe: JACIE accreditation in a processing facility.
    Caunday O, Bensoussan D, Decot V, Bordigoni P, Stoltz JF.
    Biomed Mater Eng; 2009 Mar; 19(4-5):373-9. PubMed ID: 20042804
    [Abstract] [Full Text] [Related]

  • 10. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies.
    Abbasalizadeh S, Baharvand H.
    Biotechnol Adv; 2013 Dec; 31(8):1600-23. PubMed ID: 23962714
    [Abstract] [Full Text] [Related]

  • 11. Coding and traceability in Iran.
    Aghayan HR, Mahdavi-Mazdeh M, Goodarzi P, Arjmand B, Emami-Razavi SH.
    Cell Tissue Bank; 2010 Nov; 11(4):397-400. PubMed ID: 20953716
    [Abstract] [Full Text] [Related]

  • 12. Initiation of bone and amnion banking in Turkey.
    Yilmaz Erkol A, Haznedaroglu H, Ozkara T, Taskin H.
    Cell Tissue Bank; 2003 Nov; 4(2-4):169-72. PubMed ID: 15256856
    [Abstract] [Full Text] [Related]

  • 13. Bacteriology laboratories and musculoskeletal tissue banks in Australia.
    Varettas K.
    ANZ J Surg; 2012 Nov; 82(11):775-9. PubMed ID: 22882601
    [Abstract] [Full Text] [Related]

  • 14. The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Brazil.
    Herson MR, Mathor MB, Morales Pedraza J.
    Cell Tissue Bank; 2009 May; 10(2):143-7. PubMed ID: 18618294
    [Abstract] [Full Text] [Related]

  • 15. Regulation of cellular therapies: the Australian perspective.
    Wall DM, Prince HM.
    Cytotherapy; 2003 May; 5(4):284-8. PubMed ID: 12944233
    [Abstract] [Full Text] [Related]

  • 16. Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).
    Warkentin PI, Foundation for the Accreditation of Cellular Therapy.
    Cytotherapy; 2003 May; 5(4):299-305. PubMed ID: 12944235
    [Abstract] [Full Text] [Related]

  • 17. Quality control system to support comparability assessment for the Renal Bio-Replacement therapy system.
    Pitkin Z.
    Dev Biol (Basel); 2005 May; 122():131-8. PubMed ID: 16375257
    [Abstract] [Full Text] [Related]

  • 18. [New Croatian legislation on tissue banking].
    Busić M.
    Acta Med Croatica; 2007 Dec; 61(5):445-7. PubMed ID: 18350803
    [Abstract] [Full Text] [Related]

  • 19. A review of the International Atomic Energy Agency (IAEA) international standards for tissue banks.
    Morales Pedraza J, Lobo Gajiwala A, Martinez Pardo ME.
    Cell Tissue Bank; 2012 Mar; 13(1):15-25. PubMed ID: 20714807
    [Abstract] [Full Text] [Related]

  • 20. The evolution and impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Asia and the Pacific region.
    Morales Pedraza J, Phillips GO.
    Cell Tissue Bank; 2009 May; 10(2):87-91. PubMed ID: 18575961
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.